GLP-1 Receptor Agonist Use Linked to Reduced Risks for Substance Use Disorder - Ophthalmology Advisor

AI Briefing

• – GLP-1 Receptor Agonist Use Linked to Reduced Risks for Substance Use Disorder
• – GLP-1 drugs may fight addiction across every major substance
• – Evidence is starting to mount for GLP-1 medications as a potential new treatment for addiction